Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates

Company Performance - Alignment Healthcare reported a quarterly loss of $0.16 per share, better than the Zacks Consensus Estimate of a loss of$ 0.18, and an improvement from a loss of $0.25 per share a year ago, representing an earnings surprise of 11.11% [1] - The company posted revenues of$ 701.24 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 3.58%, and showing significant growth from year-ago revenues of $465.39 million [2] - Over the last four quarters, Alignment Healthcare has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Outlook - The immediate price movement of Alignment Healthcare's stock will largely depend on management's commentary during the earnings call and future earnings expectations [3] - The stock has gained approximately 17% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is -$ 0.20 on revenues of $848.58 million, and for the current fiscal year, it is -$ 0.47 on revenues of $3.44 billion [7] - The estimate revisions trend for Alignment Healthcare is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical Services industry, to which Alignment Healthcare belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]